Our first product HisTLAND is officially launched and available for researchers.

Mukund, our CEO, presented the story of NEXUS at the KI Innovation InvestorDay2026 in front of full room of investors, entrepreneurs from startups and people interested in science in general.

Basam, joined NEUXS as Sales strategist to build the commercial strategy roadmap for our products, HisTLAND and MeTLAND.

NEXUS moved into Fysiologen in KI Solna campus to be closer to the researchers at Karolinska Institutet and thrive in the startup supportive environment that is built in the area..

NEXUS was supported by KI Innovation and SU Ventures.

Jana, our COO, presented NEXUS at KI Career Service Internship Program Mingle.

Jutta joined the R&D team as a R&D Scientist to accelerate the development of HisTLAND, our histone modification profiling product.

NEXUS was proud to present at ChaSE 2025.

NEXUS awarded the Vinnova Innovative Startups Grant!

Akshaya joined the R&D team as a Research Assistant, strengthening our assay development and validation efforts.

Brian represented NEXUS at the XCELLS Conference on Epigenetics and Health in Brussels, sharing our progress and expanding partnerships.

Brian joined NEXUS as Business Development Strategist, helping drive customer outreach and early-access program growth.

NEXUS was awarded an ERC Proof of Concept grant in collaboration with the Castelo-Branco Lab at Karolinska Institutet and the Bartosovic Lab at Stockholm University.

Our CEO Mukund and COO Jana presented NEXUS at the KI Innovations Investor Day 2025, showcasing our platform and future roadmap.

Our CEO and Co-Founder Mukund, was selected as one of ten recipients of the FUHS x SEB Innovation Scholarship for promising startup founders.

NEXUS won the Dragons’ Den pitch competition during the KI Innovations DRIVE Program, placing first among all competing startups.

NEXUS received a Seal of Excellence from the European Research Council for the MeTLAND project.